Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

A Systematic Review and Meta-Analysis of Adenosine Administration and Cardioversion in Pediatric Patients with Supraventricular Tachycardia

  • By

  • Laís dos Santos

  • Thaís Martins Shehan

  • Candela Lang

  • Ricardo Sanchez Algarin

  • Ingrid Bezerra de Oliveira Ribeiro

  • Paulo Cesar Mattos Dourado de Mesquita

  • Guilherme Dagostin de Carvalho

  • June 5, 2026

Share

  • 1

    Supraventricular tachycardia (SVT) is the most common arrhythmia in children, with an incidence of 1 in 250 to 1 in 1000.

  • 2

    Intravenous adenosine is the first-line treatment for SVT due to its rapid onset and favorable safety profile.

  • 3

    There is significant variability in adenosine dosing across clinical settings, indicating uncertainty about optimal dosing for cardioversion.

  • 4

    The systematic review aimed to evaluate weight-based adenosine dosing and its success in achieving cardioversion in pediatric patients.

  • 5

    Subgroup analyses were conducted to assess cardioversion outcomes based on different weight-based adenosine dose categories.

Original Source(s)

Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis

  • by Laís dos Santos, Thaís Martins Shehan, Candela Lang, Ricardo Sanchez Algarin, Ingrid Bezerra de Oliveira Ribeiro, Paulo Cesar Mattos Dourado de Mesquita, Guilherme Dagostin de Carvalho

  • June 5, 2026

Related Content

How Does Social Media Influence Health Decisions?

National survey findings suggest many US adults report making health decisions based on social media despite widespread concerns about the accuracy of health information shared to the platforms.

Systematic benchmark of reduced-lead configurations for 12-lead ECG reconstruction: multi-model evaluation across all possible subsets

HHS Proposes Mandatory GRAS Notices

Manufacturers would be required to notify the FDA of GRAS determinations under a proposed rule, while HHS and USDA also submitted the first proposed federal definition of ultra-processed foods for final review.